Commission Announces Agenda for Roundtable on Follow-on Biologic Drugs
Date
The Federal Trade Commission has announced the agenda for the upcoming public roundtable on “Follow-on Biologic Drugs: Framework for Competition and Continued Innovation.” The roundtable will be held...